18 Results for "

SK-MEL-28 cell

" in MedChemExpress (MCE) Product Catalog:
Products (18)

18 Results for "SK-MEL-28 cell" in MCE Product Catalog:

99
99 Publications Verification
Cat. No.: HY-B0150
CAS No.: 98-92-0
Synonyms: Niacinamide; Nicotinic acid amide
Nicotinamide is a form of vitamin B3 or niacin. Nicotinamide Hydrochloride inhibits SIRT2 activity (IC50: 2 μM). Nicotinamide also inhibits SIRT1. Nicotinamide increases cellular NAD+, ATP, ROS levels. Nicotinamide inhibits tumor growth and improves survival. Nicotinamide also has anti-HBV activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-14454
CAS No.: 21306-65-0
Purity:  99.81%
Synonyms: Triphenyl Compound A
Research Areas:  

Cancer

TPh A (Triphenyl Compound A) is a potent inhibitor of the nuclear protein pirin and binds specifically to pirin with a Ki of 0.6 uM. TPh A disrupts the formation of the bcl3–pirin complex. TPh A can be used as a novel small molecule tool to regulate pirin in cells .
loading...
    loading...
Cat. No.: HY-124113
CAS No.: 1224713-90-9
Purity:  99.94%
Synonyms: 4′‐BR
4'-Bromo-resveratrol (4′‐BR) is a dual SIRT1/SIRT3 inhibitor with an IC50 of 0.2 mM for both targets. 4'-Bromo-resveratrol induces caspase-dependent apoptosis, induces G0/G1 cell cycle arrest, and inhiibits proliferation. 4'-Bromo-resveratrol reduces lactate production, glucose uptake, and NAD +/NADH ratio, and downregulates lactate dehydrogenase A and glucose transporter 1 (GLUT1). 4'-Bromo-resveratrol can be used for the research of melanoma .
loading...
    loading...
Cat. No.: HY-170982
CAS No.: 2756323-28-9
Target:  

PROTACs MEK

Research Areas:  

Cancer

MS910 is a CRBN-recruiting MEK1/2 PROTAC degrader, with a DC50 of 94 nM against MEK1 and 38 nM against MEK2 in SK-MEL-28 cells. MS910 induces the degradation of GSPT1, IKZF1/3 and ZFP91, thereby inhibiting the downstream ERK signaling pathway and cancer cell growth. MS910 is applicable to research related to colorectal cancer and melanoma .
loading...
    loading...
Cat. No.: HY-N4006
CAS No.: 129280-34-8
Isoangustone A is an anticancer and anti-inflammatory agent. Isoangustone A induces cancer cells apoptosis and autophagic cell death .
loading...
    loading...
Cat. No.: HY-B0150A
CAS No.: 25334-23-0
Synonyms: Niacinamide hydrochloride; Nicotinic acid amide hydrochloride
Nicotinamide hydrochloride is a form of vitamin B3 or niacin. Nicotinamide hydrochloride inhibits SIRT2 activity (IC50: 2 μM). Nicotinamide hydrochloride also inhibits SIRT1. Nicotinamide hydrochloride increases cellular NAD+, ATP, ROS levels. Nicotinamide hydrochloride inhibits tumor growth and improves survival. Nicotinamide hydrochloride also has anti-HBV activity .
loading...
    loading...
Cat. No.: HY-155315
CAS No.: 2998928-27-9
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

Tubulin polymerization-IN-51(compound 7u) is a tubulin polymerization inhibitor with IC50 value of 2.55 - 17.89μM for SK-Mel-28 cells. Tubulin polymerization-IN-51 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-155314
CAS No.: 2998928-21-3
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

Tubulin polymerization-IN-50 (compound 7n) is a inhibitor of tubulin polymerization, with the IC50 of 5.05 μM in SK-Mel-28 cells. Tubulin polymerization-IN-50 induces the cell cycle arrest in the G2/M phase .
loading...
    loading...
Cat. No.: HY-175435
CAS No.: 3094183-98-6
Target:  

PROTACs Raf ERK

Research Areas:  

Neurological Disease Cancer

CST905 is a potent BRAF-V600E PROTAC degrader with a DC50 of 18 nM. CST905 recruits the VHL E3 ligase to form a ternary complex, mediating the degradation of BRAF-V600E via the ubiquitin-proteasome pathway. The ligand of CST905 disrupts the RAF dimerization interface, thereby preventing the aberrant activation of the harmful MAPK/ERK pathway in RAS-mutated cells while degrading the target protein. CST905 can be used in studies related to malignant melanoma and neuroblastoma .
loading...
    loading...
Cat. No.: HY-162045
Research Areas:  

Cancer

Ru-4T is a phototherapy agent. Ru-4T has phototherapeutic efficacy (PI = 114,000) against melanoma cells (SK-MEL-28) under broad-band visible light (400-700 nm) with EC50 values of 740 pM .
loading...
    loading...
Cat. No.: HY-W317408
CAS No.: 5157-89-1
Research Areas:  

Others

(+)-Menthyl acetate is a compound isolated from natural Cunila angustifolia Benth essential oil. The selectivity of (+)-Menthyl acetate is higher than that of MCF-7 cell line, IC50=34.0 μg?mL -1, and lower than that of SK-Mel-28 cell line, IC50=279.9 μg?mL -1, on A549 cell without fatal .
loading...
    loading...
Cat. No.: HY-W010978
CAS No.: 873779-78-3
Research Areas:  

Cancer

IMesCuCl is a neutral (NHC) copper (I) complex. IMesCuCl exhibits cytotoxic activity against cancer cells. IMesCuCl can be used in the research of breast cancer, lung cancer, melanoma and glioma .
loading...
    loading...
Cat. No.: HY-164400
CAS No.: 839707-55-0
Target:  

MEK ERK Akt Apoptosis

Research Areas:  

Cancer

SIJ1777 is a GNF-7 (HY-10943) derivative, possesses potent anti-cancer effects on melanoma cells harboring BRAF class I/II/III mutations. SIJ1777 substantially inhibits the activation of MEK, ERK, and AKT. SIJ1777 remarkably induces apoptosis and significantly blocks migration, invasion, and anchorage-independent growth of melanoma cells harboring BRAF class I/II/II mutations .
loading...
    loading...
Cat. No.: HY-B0150G
CAS No.: 98-92-0
Synonyms: Niacinamide (GMP); Nicotinic acid amide (GMP)
Nicotinamide (GMP) (Niacinamide (GMP)) is the GMP level of Nicotinamide (HY-B0150). GMP guidelines are used to produce Nicotinamide (GMP). GMP small molecules works appropriately as an auxiliary reagent for cell research manufacture. Nicotinamide is a form of vitamin B3 or niacin. Nicotinamide Hydrochloride inhibits SIRT2 activity (IC50: 2 μM). Nicotinamide also inhibits SIRT1. Nicotinamide increases cellular NAD+, ATP, ROS levels. Nicotinamide inhibits tumor growth and improves survival. Nicotinamide also has anti-HBV activity .
loading...
    loading...
Cat. No.: HY-W035150
CAS No.: 578743-87-0
Research Areas:  

Cancer

Chloro[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene]copper(I) (Compound 1) is a NHC copper complex and anticancer agent. Chloro[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene]copper(I) exhibits cytotoxic activity against breast cancer, lung cancer, melanoma, and glioma cells .
loading...
    loading...
Cat. No.: HY-181545A
CAS No.: 3124168-27-7
Target:  

NO Synthase IFNAR

Research Areas:  

Cancer

nNOS-IN-2 trihydrochloride is a blood-brain barrier-permeable nitric oxide synthase (nNOS) inhibitor. nNOS-IN-2 trihydrochloride exhibits Ki values of 1.7 nM and 2.3 nM against human and rat nNOS, respectively, and shows high selectivity for human eNOS and iNOS. nNOS-IN-2 trihydrochloride also effectively reduces PD-L1 expression in human melanoma cells under both basal conditions and IFN-γ exposure. nNOS-IN-2 trihydrochloride can be used for the study of melanoma and related signaling pathways .
loading...
    loading...
Cat. No.: HY-183877
CAS No.: 288254-44-4
Target:  

MDM-2/p53 Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

YO-2 is a plasmin inhibitor and TP53 upregulator with anti-tumor and apoptosis-inducing activities. YO-2 upregulates the expression of TP53 and the tumor-suppressive miR-103/107, downregulates LRP1, and induces cellular DNA fragmentation and caspase cascade activation. YO-2 effectively blocks the growth of melanoma. YO-2 has been widely used in studies related to melanoma and colon cancer .
loading...
    loading...
Cat. No.: HY-188125
CAS No.: 207384-96-1
Target:  

Endogenous Metabolite

Research Areas:  

Cancer

Globo H is a carbohydrate antigen belonging to the globo-series glycosphingolipids, and its non-reducing terminal tetrasaccharide fragment serves as the core epitope recognized by antibodies. Globo H is upregulated in a variety of human cancer tissues, and is also present in some normal fetal and adult epithelial tissues. Globo H can be used in cancer-related research .
loading...
    loading...
  • 1